Levinthal Biotech
力文所
Levinthal Biotech (力文所) is a Hangzhou-based company developing AI-powered protein design, operating the self-built Lésign® intelligent protein design platform and the all-atom generative model Pallatom . ZhenFund (真格基金) invested in the company's seed round in 2021 and continued to follow on in its angel round . In late 2025, the company raised tens of millions of RMB in a Pre-A round led by Jinyu Maowu with Junke Danmu participating, with funds directed toward Pallatom iteration, commercial pipeline expansion, and global talent recruitment . The company was also named to the first batch of typical application cases for AI in bio-manufacturing by China's Ministry of Industry and Information Technology .
AI-generated — may contain errors, please verify.
Coverage
ZhenFund angel project "Livinova" completes tens of millions of yuan in Pre-A funding; self-developed all-atom model Pallatom makes NVIDIA's recommended list
The new funding will accelerate iterative upgrades to Pallatom, its full-atom model protein design platform, expand its commercial pipeline, and support global talent recruitment.
真格基金·Venture Where No One Has Gone Before | Z News
July is drawing to a close, and we invite you to join us in witnessing the growth of our portfolio companies and what's new at ZhenFund.
真格基金·Late Summer Sun, Breezes Bringing Autumn | Z News
A gentle breeze blows warm and pleasant.
真格基金·
